and foreign markets, our ability to commercialize our product candidates successfully, and to attract commercialization partners for our product candidates, depends in significant part on the availability of adequate financial coverage and reimbursement from third-party payers, including, in the U.S., governmental payers such as the Medicare and Medicaid programs, managed care organizations, and private health insurers
Hu H, Shao W, Liu Q et al (2022) Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion
What this post covers: Where GLP-1 receptors sit in the brain and why that matters for reward and compulsion The clinical trial pipeline for GLP-1 agonists in addiction (alcohol, nicotine, opioids) Why anhedonia may be a dosing problem, not a drug problem, and the ziprasidone parallel Real-world observations from low-dose tirzepatide combined with ketogenic diets The scope-of-practice question: should psychiatrists be prescribing GLP-1 agonists
Dosing As we discussed previously, many athletes choose to supplement with both standard L-Carnitine as well as Acetyl -L-Carnitine, particularly if their goals lie in improving cognitive function along with physical performance